Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.

NPJ Vaccines · 2026 · PMC13324253 · PMID 42045246

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

For the 3 tandem repeat immunogen with N-terminal PADRE (PADRE-LuS-3T) the responses were significantly higher against the major repeat probe (NANP9) and showed a trend toward higher responses against PfCSP and NPDP19, but these differences were not significant (Fig. 3b , comparing groups 6 and 7 at week 6).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

However, these differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.